{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T23:04:14Z","timestamp":1789340654037,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":103,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Foundation of Pudong New Area Health System Medical Talent Training Program","award":["no. PWRl2022-06"],"award-info":[{"award-number":["no. PWRl2022-06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02140-4","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:18:02Z","timestamp":1780453082000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circ-MAP4K3 promotes papillary thyroid cancer progression by sponging miR-758-3p to enhance RRM2 expression"],"prefix":"10.1007","volume":"26","author":[{"given":"Yi","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangnan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"2140_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1146\/annurev-med-061512-105739","volume":"65","author":"T Carling","year":"2014","unstructured":"Carling T, Udelsman R. Thyroid cancer. Annu Rev Med. 2014;65:125\u201337.","journal-title":"Annu Rev Med"},{"issue":"10061","key":"2140_CR2","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/S0140-6736(16)30172-6","volume":"388","author":"ME Cabanillas","year":"2016","unstructured":"Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet (London England). 2016;388(10061):2783\u201395.","journal-title":"Lancet (London England)"},{"issue":"4","key":"2140_CR3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/cen.12845","volume":"84","author":"AS Alzahrani","year":"2016","unstructured":"Alzahrani AS, Alkhafaji D, Tuli M, Al-Hindi H, Sadiq BB. Comparison of differentiated thyroid cancer in children and adolescents (\u2264\u200920 years) with young adults. Clin Endocrinol. 2016;84(4):571\u20137.","journal-title":"Clin Endocrinol"},{"issue":"6","key":"2140_CR4","doi-asserted-by":"publisher","first-page":"R311","DOI":"10.1530\/ERC-15-0381","volume":"22","author":"MI Cordioli","year":"2015","unstructured":"Cordioli MI, Moraes L, Cury AN, Cerutti JM. Are we really at the dawn of understanding sporadic pediatric thyroid carcinoma? Endocrine-related Cancer. 2015;22(6):R311\u2013324.","journal-title":"Endocrine-related Cancer"},{"key":"2140_CR5","doi-asserted-by":"crossref","unstructured":"Toraih EA, Hussein MH, Zerfaoui M, Attia AS, Marzouk Ellythy A, Mostafa A, Ruiz EML, Shama MA, Russell JO, Randolph GW, Kandil E. Site-Specific Metastasis and Survival in Papillary Thyroid Cancer: The Importance of Brain and Multi-Organ Disease. Cancers (Basel). 2021; 13(7).","DOI":"10.3390\/cancers13071625"},{"issue":"5","key":"2140_CR6","doi-asserted-by":"publisher","first-page":"796","DOI":"10.21147\/j.issn.1000-9604.2025.05.11","volume":"37","author":"W Xia","year":"2025","unstructured":"Xia W, Liu J, Chen R, Feng J, Wu L, Wang Y, Wang X, Song C, Mao W. Molecular subtypes and prognostic signature rooted in disulfidptosis highlight tumor microenvironment in lung adenocarcinoma. Chin J Cancer Res. 2025;37(5):796\u2013820.","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"2140_CR7","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41746-025-02172-2","volume":"8","author":"Z Gong","year":"2025","unstructured":"Gong Z, Du M, Li Y, Ye B, Huang Y, Gong H, Wang W, Chen L, Ding Z, Zhang P. Machine learning identifies TIME subtypes linking EGFR mutations and immune states in lung adenocarcinoma. NPJ Digit Med. 2025;8(1):796.","journal-title":"NPJ Digit Med"},{"issue":"6","key":"2140_CR8","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.21147\/j.issn.1000-9604.2025.06.11","volume":"37","author":"P Zhang","year":"2025","unstructured":"Zhang P, Liang X, Ye B, Wang X, Wang Y, Gong Z, Huang Y, Liu J, Huang C, Luo P. Metabolic reprogramming signature predicts immunotherapy efficacy in lung adenocarcinoma: Targeting SLC25A1 to overcome immune resistance. Chin J Cancer Res. 2025;37(6):1000\u201319.","journal-title":"Chin J Cancer Res"},{"issue":"11","key":"2140_CR9","doi-asserted-by":"publisher","first-page":"894","DOI":"10.2174\/0109298665341953240926041613","volume":"31","author":"D Liang","year":"2024","unstructured":"Liang D, Zhang Q, Pang Y, Yan R, Ke Y. SGSM2 in Uveal Melanoma: Implications for Survival, Immune Infiltration, and Drug Sensitivity. Protein Pept Lett. 2024;31(11):894\u2013905.","journal-title":"Protein Pept Lett"},{"issue":"2","key":"2140_CR10","doi-asserted-by":"publisher","first-page":"2244515","DOI":"10.1080\/07853890.2023.2244515","volume":"55","author":"B Wang","year":"2023","unstructured":"Wang B, Shen W, Yan L, Li X, Zhang L, Zhao S, Jin X. Reveal the potential molecular mechanism of circRNA regulating immune-related mRNA through sponge miRNA in the occurrence and immune regulation of papillary thyroid cancer. Ann Med. 2023;55(2):2244515.","journal-title":"Ann Med"},{"issue":"6","key":"2140_CR11","doi-asserted-by":"publisher","first-page":"e90859","DOI":"10.1371\/journal.pone.0090859","volume":"9","author":"PL Wang","year":"2014","unstructured":"Wang PL, Bao Y, Yee MC, Barrett SP, Hogan GJ, Olsen MN, Dinneny JR. Brown PO and Salzman J. Circular RNA is expressed across the eukaryotic tree of life. PLoS ONE. 2014;9(6):e90859.","journal-title":"PLoS ONE"},{"issue":"5","key":"2140_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nbt.2890","volume":"32","author":"WR Jeck","year":"2014","unstructured":"Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32(5):453\u201361.","journal-title":"Nat Biotechnol"},{"issue":"9","key":"2140_CR13","doi-asserted-by":"publisher","first-page":"e1003777","DOI":"10.1371\/journal.pgen.1003777","volume":"9","author":"J Salzman","year":"2013","unstructured":"Salzman J, Chen RE, Olsen MN, Wang PL, Brown PO. Cell-type specific features of circular RNA expression. PLoS Genet. 2013;9(9):e1003777.","journal-title":"PLoS Genet"},{"issue":"3","key":"2140_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2174\/0109298665339026250114070523","volume":"32","author":"X Li","year":"2025","unstructured":"Li X, Liu J, He L, Tian M, Xu Y, Peng B. miR-584-5p Regulates MSMO1 to Modulate the AKT\/PI3K Pathway and Inhibit Breast Cancer Progression. Protein Pept Lett. 2025;32(3):171\u201382.","journal-title":"Protein Pept Lett"},{"issue":"2","key":"2140_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.canlet.2015.06.003","volume":"365","author":"S Qu","year":"2015","unstructured":"Qu S, Yang X, Li X, Wang J, Gao Y, Shang R, Sun W, Dou K, Li H. Circular RNA: A new star of noncoding RNAs. Cancer Lett. 2015;365(2):141\u20138.","journal-title":"Cancer Lett"},{"issue":"7441","key":"2140_CR16","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384\u20138.","journal-title":"Nature"},{"key":"2140_CR17","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.12659\/MSM.913463","volume":"25","author":"H Wang","year":"2019","unstructured":"Wang H, Yan X, Zhang H, Zhan X. CircRNA circ_0067934 Overexpression Correlates with Poor Prognosis and Promotes Thyroid Carcinoma Progression. Med Sci monitor: Int Med J experimental Clin Res. 2019;25:1342\u20139.","journal-title":"Med Sci monitor: Int Med J experimental Clin Res"},{"issue":"9","key":"2140_CR18","doi-asserted-by":"publisher","first-page":"107564","DOI":"10.1016\/j.isci.2023.107564","volume":"26","author":"L Dai","year":"2023","unstructured":"Dai L, Zhang W, Wang Y, Yu K, Le Q, Wu X. circAGTPBP1 promotes the progression of papillary thyroid cancer through the notch pathway via the miR-34a-5p\/notch1 axis. iScience. 2023;26(9):107564.","journal-title":"iScience"},{"issue":"43","key":"2140_CR19","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1038\/s41388-023-02830-3","volume":"42","author":"X Yao","year":"2023","unstructured":"Yao X, Liu H, Wang Z, Lu F, Chen W, Feng Q, Miao Y, Zhang J, Wang Y, Chen Y, Xue L, Liu Y, Chen L, et al. Circular RNA EIF3I promotes papillary thyroid cancer progression by interacting with AUF1 to increase Cyclin D1 production. Oncogene. 2023;42(43):3206\u201318.","journal-title":"Oncogene"},{"issue":"10","key":"2140_CR20","doi-asserted-by":"publisher","first-page":"e24688","DOI":"10.1002\/jcla.24688","volume":"36","author":"D Chen","year":"2022","unstructured":"Chen D, Jiang X, Luo H, Hua Q, Zhang F. CircPTPRM accelerates malignancy of papillary thyroid cancer via miR-885-5p\/DNMT3A axis. J Clin Lab Anal. 2022;36(10):e24688.","journal-title":"J Clin Lab Anal"},{"issue":"3","key":"2140_CR21","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s40618-022-01928-x","volume":"46","author":"C Shu","year":"2023","unstructured":"Shu C, Wang S, Hu J, Xu M, Deng H, Maimaiti Y, Huang T. CircNDST1 promotes papillary thyroid cancer progression via its interaction with CSNK2A1 to activate the PI3K-Akt pathway and epithelial-mesenchymal transition. J Endocrinol Investig. 2023;46(3):545\u201357.","journal-title":"J Endocrinol Investig"},{"issue":"4","key":"2140_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.trecan.2020.01.012","volume":"6","author":"J Li","year":"2020","unstructured":"Li J, Sun D, Pu W, Wang J, Peng Y. Circular RNAs in Cancer: Biogenesis, Function, and Clinical Significance. Trends cancer. 2020;6(4):319\u201336.","journal-title":"Trends cancer"},{"key":"2140_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.imlet.2022.04.004","volume":"246","author":"L Chen","year":"2022","unstructured":"Chen L, Zhuo D, Yuan H. Circ_100395 impedes malignancy and glycolysis in papillary thyroid cancer: Involvement of PI3K\/AKT\/mTOR signaling pathway. Immunol Lett. 2022;246:10\u20137.","journal-title":"Immunol Lett"},{"issue":"1","key":"2140_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41598-024-84548-0","volume":"15","author":"W Ou","year":"2025","unstructured":"Ou W, Tan R, Zhai J, Sun L, Quan Z, Huang X, Xu F, Xu Q, Zhou C. Silencing circ_0043256 inhibited CoCl2-induced proliferation, migration, and aerobic glycolysis in gastric cancer cells. Sci Rep. 2025;15(1):171.","journal-title":"Sci Rep"},{"issue":"19","key":"2140_CR25","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.21037\/atm-20-4460","volume":"8","author":"L Zhao","year":"2020","unstructured":"Zhao L, Wei J, Wang S, Lang T, Shi X, Shan Z, Teng W. Beta-elemene inhibits differentiated thyroid carcinoma metastasis by reducing cellular proliferation, metabolism and invasion ability. Ann Transl Med. 2020;8(19):1232.","journal-title":"Ann Transl Med"},{"key":"2140_CR26","doi-asserted-by":"crossref","unstructured":"Zhu G, Chang X, Kang Y, Zhao X, Tang X, Ma C, Fu S. CircRNA: A novel potential strategy to treat thyroid cancer (Review). Int J Mol Med. 2021; 48(5).","DOI":"10.3892\/ijmm.2021.5034"},{"issue":"10","key":"2140_CR27","doi-asserted-by":"publisher","first-page":"153217","DOI":"10.1016\/j.prp.2020.153217","volume":"216","author":"S Borran","year":"2020","unstructured":"Borran S, Ahmadi G, Rezaei S, Anari MM, Modabberi M, Azarash Z, Razaviyan J, Derakhshan M, Akhbari M, Mirzaei H. Circular RNAs: New players in thyroid cancer. Pathol Res Pract. 2020;216(10):153217.","journal-title":"Pathol Res Pract"},{"issue":"3\u20134","key":"2140_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41417-020-00218-z","volume":"28","author":"W Zhang","year":"2021","unstructured":"Zhang W, Liu T, Li T, Zhao X. Hsa_circRNA_102002 facilitates metastasis of papillary thyroid cancer through regulating miR-488-3p\/HAS2 axis. Cancer Gene Ther. 2021;28(3\u20134):279\u201393.","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"2140_CR29","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1186\/s12967-024-05405-2","volume":"22","author":"JJ Li","year":"2024","unstructured":"Li JJ, Ru ZX, Yang X, Sun JX, Wu YM, Yang XY, Hou BY, Xue B, Ding C, Qiao H. Circ_0004851 regulates the molecular mechanism of miR-296-3p\/FGF11 in the influence of high iodine on PTC. J Transl Med. 2024;22(1):586.","journal-title":"J Transl Med"},{"key":"2140_CR30","doi-asserted-by":"publisher","first-page":"e2501010","DOI":"10.4014\/jmb.2501.01010","volume":"35","author":"M Liu","year":"2025","unstructured":"Liu M, Zhang L, Yan Z. EIF4A3-Induced Circ_0092278 Enhances Papillary Thyroid Cancer Cell Malignancy by the PI3K\/Akt\/mTOR Signaling Pathway. J Microbiol Biotechnol. 2025;35:e2501010.","journal-title":"J Microbiol Biotechnol"},{"issue":"4","key":"2140_CR31","first-page":"1362","volume":"12","author":"MY Long","year":"2020","unstructured":"Long MY, Chen JW, Zhu Y, Luo DY, Lin SJ, Peng XZ, Tan LP, Li HH. Comprehensive circular RNA profiling reveals the regulatory role of circRNA_0007694 in papillary thyroid carcinoma. Am J Transl Res. 2020;12(4):1362\u201378.","journal-title":"Am J Transl Res"},{"issue":"4","key":"2140_CR32","first-page":"4288","volume":"18","author":"Z Wang","year":"2019","unstructured":"Wang Z, Han Z, Zhang L, Zhang S, Wang B. MicroRNA-98-5p regulates the proliferation and apoptosis of A549 cells by targeting MAP4K3. Oncol Lett. 2019;18(4):4288\u201393.","journal-title":"Oncol Lett"},{"issue":"4","key":"2140_CR33","doi-asserted-by":"publisher","first-page":"531","DOI":"10.23736\/S0026-4806.19.06251-7","volume":"112","author":"Y Song","year":"2021","unstructured":"Song Y, Zhang F, Li L, Song B, Xu J, Wang G, Zheng Z. MiR-338-3p inhibits growth of glioblastoma through targeting MAP4K3. Minerva Med. 2021;112(4):531\u20133.","journal-title":"Minerva Med"},{"key":"2140_CR34","doi-asserted-by":"crossref","unstructured":"Shi Y, Mo X, Hong S, Li T, Chen B, Chen G. Studying the Role and Molecular Mechanisms of MAP4K3 in Sorafenib Resistance of Hepatocellular Carcinoma. BioMed research international. 2020; 2020:4965670.","DOI":"10.1155\/2020\/4965670"},{"issue":"2","key":"2140_CR35","first-page":"1786","volume":"18","author":"T Song","year":"2019","unstructured":"Song T, Hou X, Lin B. MicroRNA-758 inhibits cervical cancer cell proliferation and metastasis by targeting HMGB3 through the WNT\/\u03b2-catenin signaling pathway. Oncol Lett. 2019;18(2):1786\u201392.","journal-title":"Oncol Lett"},{"key":"2140_CR36","doi-asserted-by":"publisher","first-page":"5337","DOI":"10.2147\/CMAR.S311242","volume":"13","author":"H Xie","year":"2021","unstructured":"Xie H, Wang J, Wang B. Circular RNA Circ_0003221 Promotes Cervical Cancer Progression by Regulating miR-758-3p\/CPEB4 Axis. Cancer Manage Res. 2021;13:5337\u201350.","journal-title":"Cancer Manage Res"},{"issue":"10","key":"2140_CR37","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s12033-023-00661-x","volume":"65","author":"C Sun","year":"2023","unstructured":"Sun C, Zhang J, Liu J, Tong J, Wang P. Hsa_circ_0017956 Acts as miR-758-3p Sponge to Facilitate the Progression of Non-small-Cell Lung Cancer by Regulating FOXP4 Expression. Mol Biotechnol. 2023;65(10):1715\u201328.","journal-title":"Mol Biotechnol"},{"issue":"1","key":"2140_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10911-022-09514-w","volume":"27","author":"D Kong","year":"2022","unstructured":"Kong D, Shen D, Liu Z, Zhang J, Zhang J, Geng C. Circ_0008500 Knockdown Improves Radiosensitivity and Inhibits Tumorigenesis in Breast Cancer Through the miR-758-3p\/PFN2 Axis. J Mammary Gland Biol Neoplasia. 2022;27(1):37\u201352.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"13","key":"2140_CR39","doi-asserted-by":"publisher","first-page":"17155","DOI":"10.18632\/aging.203062","volume":"13","author":"ZJ Zhu","year":"2021","unstructured":"Zhu ZJ, Pang Y, Jin G, Zhang HY, Wang WH, Liu JW, Tuo GX, Wu P, Yang Y, Wang ZQ, Wang K. Hypoxia induces chemoresistance of esophageal cancer cells to cisplatin through regulating the lncRNA-EMS\/miR-758-3p\/WTAP axis. Aging. 2021;13(13):17155\u201376.","journal-title":"Aging"},{"key":"2140_CR40","doi-asserted-by":"crossref","unstructured":"Klimaszewska-Wi\u015bniewska A, Buchholz K, Neska-D\u0142ugosz I, Dur\u015blewicz J, Grzanka D, Zabrzy\u0144ski J, Sopo\u0144ska P, Grzanka A, Gagat M. Expression of Genomic Instability-Related Molecules: Cyclin F, RRM2 and SPDL1 and Their Prognostic Significance in Pancreatic Adenocarcinoma. Cancers. 2021; 13(4).","DOI":"10.3390\/cancers13040859"},{"issue":"3","key":"2140_CR41","doi-asserted-by":"publisher","first-page":"546","DOI":"10.4149\/neo_2021_200914N981","volume":"68","author":"XB Cheng","year":"2021","unstructured":"Cheng XB, Zhang T, Zhu HJ, Ma N, Sun XD, Wang SH, Jiang Y. Knockdown of lncRNA SNHG4 suppresses gastric cancer cell proliferation and metastasis by targeting miR-204-5p. Neoplasma. 2021;68(3):546\u201356.","journal-title":"Neoplasma"},{"issue":"8","key":"2140_CR42","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.7150\/thno.53176","volume":"11","author":"WC Cheng","year":"2021","unstructured":"Cheng WC, Chang CY, Lo CC, Hsieh CY, Kuo TT, Tseng GC, Wong SC, Chiang SF, Huang KC, Lai LC, Lu TP, Chao KSC, Sher YP. Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma. Theranostics. 2021;11(8):3661\u201375.","journal-title":"Theranostics"},{"key":"2140_CR43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2147\/JHC.S294108","volume":"8","author":"Z Wang","year":"2021","unstructured":"Wang Z, Embaye KS, Yang Q, Qin L, Zhang C, Liu L, Zhan X, Zhang F, Wang X, Qin S. A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma. J hepatocellular carcinoma. 2021;8:119\u201332.","journal-title":"J hepatocellular carcinoma"},{"issue":"1","key":"2140_CR44","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1186\/s12935-020-01689-8","volume":"20","author":"Y Yang","year":"2020","unstructured":"Yang Y, Lin J, Guo S, Xue X, Wang Y, Qiu S, Cui J, Ma L, Zhang X, Wang J. RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer. Cancer Cell Int. 2020;20(1):587.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"2140_CR45","doi-asserted-by":"publisher","first-page":"e0265195","DOI":"10.1371\/journal.pone.0265195","volume":"17","author":"SC Shi","year":"2022","unstructured":"Shi SC, Zhang Y, Wang T. High RRM2 expression has poor prognosis in specific types of breast cancer. PLoS ONE. 2022;17(3):e0265195.","journal-title":"PLoS ONE"},{"key":"2140_CR46","doi-asserted-by":"crossref","unstructured":"Mukherjee S, Kar A, Khatun N, Datta P, Biswas A, Barik S. Familiarity Breeds Strategy: In Silico Untangling of the Molecular Complexity on Course of Autoimmune Liver Disease-to-Hepatocellular Carcinoma Transition Predicts Novel Transcriptional Signatures. Cells. 2021; 10(8).","DOI":"10.3390\/cells10081917"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02140-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02140-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02140-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T23:00:11Z","timestamp":1789340411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02140-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2140"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02140-4","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was given by the Ethics Committee of The animal ethics committee at Shanghai Gongli Hospital. All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"331"}}